132 related articles for article (PubMed ID: 8811523)
1. Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption.
Barraclough M; Taylor CJ
J Pediatr Gastroenterol Nutr; 1996 Jul; 23(1):45-50. PubMed ID: 8811523
[TBL] [Abstract][Full Text] [Related]
2. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption.
Robinson PJ; Smith AL; Sly PD
Dig Dis Sci; 1990 Oct; 35(10):1299-304. PubMed ID: 2120019
[TBL] [Abstract][Full Text] [Related]
3. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency.
Abrams CK; Hamosh M; Hubbard VS; Dutta SK; Hamosh P
J Clin Invest; 1984 Feb; 73(2):374-82. PubMed ID: 6699170
[TBL] [Abstract][Full Text] [Related]
4. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.
Youngberg CA; Berardi RR; Howatt WF; Hyneck ML; Amidon GL; Meyer JH; Dressman JB
Dig Dis Sci; 1987 May; 32(5):472-80. PubMed ID: 3646103
[TBL] [Abstract][Full Text] [Related]
5. The effect of cimetidine on meal-stimulated gastric function and exogenous pancreatic enzymes in cystic fibrosis.
Cameron DJ; Pitcher-Wilmott R; Milla PJ; More J; Ghale GK; Matthew DJ; Harries JT
Hum Nutr Clin Nutr; 1982; 36(6):475-81. PubMed ID: 6925576
[TBL] [Abstract][Full Text] [Related]
6. Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion.
Armand M; Hamosh M; Philpott JR; Resnik AK; Rosenstein BJ; Hamosh A; Perman JA; Hamosh P
Pediatr Res; 2004 Mar; 55(3):457-65. PubMed ID: 14681491
[TBL] [Abstract][Full Text] [Related]
7. Role of lipase in the regulation of postprandial gastric acid secretion and emptying of fat in humans: a study with orlistat, a highly specific lipase inhibitor.
Borovicka J; Schwizer W; Guttmann G; Hartmann D; Kosinski M; Wastiel C; Bischof-Delaloye A; Fried M
Gut; 2000 Jun; 46(6):774-81. PubMed ID: 10807887
[TBL] [Abstract][Full Text] [Related]
8. Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.
Francisco MP; Wagner MH; Sherman JM; Theriaque D; Bowser E; Novak DA
J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):79-83. PubMed ID: 12142815
[TBL] [Abstract][Full Text] [Related]
9. Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.
Proesmans M; De Boeck K
Eur J Pediatr; 2003 Nov; 162(11):760-3. PubMed ID: 13680386
[TBL] [Abstract][Full Text] [Related]
10. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
Dutta SK; Hubbard VS; Appler M
Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
[TBL] [Abstract][Full Text] [Related]
11. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
[TBL] [Abstract][Full Text] [Related]
12. Lingual lipase: an important lipase in the digestion of dietary lipids in cystic fibrosis?
Fredrikzon B; Bläckberg L
Pediatr Res; 1980 Dec; 14(12):1387-90. PubMed ID: 7208157
[TBL] [Abstract][Full Text] [Related]
13. Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events.
Bijvelds MJ; Bronsveld I; Havinga R; Sinaasappel M; de Jonge HR; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2005 Apr; 288(4):G646-53. PubMed ID: 15528257
[TBL] [Abstract][Full Text] [Related]
14. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
[TBL] [Abstract][Full Text] [Related]
15. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
[TBL] [Abstract][Full Text] [Related]
16. Pancreatin preparations used in the treatment of cystic fibrosis--lipase content and in vitro release.
Walters MP; Littlewood JM
Aliment Pharmacol Ther; 1996 Jun; 10(3):433-40. PubMed ID: 8791974
[TBL] [Abstract][Full Text] [Related]
17. Effects of a proton-pump inhibitor in cystic fibrosis.
Tran TM; Van den Neucker A; Hendriks JJ; Forget P; Forget PP
Acta Paediatr; 1998 May; 87(5):553-8. PubMed ID: 9641739
[TBL] [Abstract][Full Text] [Related]
18. Acidic duodenal pH alters gene expression in the cystic fibrosis mouse pancreas.
Kaur S; Norkina O; Ziemer D; Samuelson LC; De Lisle RC
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G480-90. PubMed ID: 15064229
[TBL] [Abstract][Full Text] [Related]
19. Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract.
Armand M; Pasquier B; André M; Borel P; Senft M; Peyrot J; Salducci J; Portugal H; Jaussan V; Lairon D
Am J Clin Nutr; 1999 Dec; 70(6):1096-106. PubMed ID: 10584056
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro studies of microsphere pancreatic supplements.
Littlewood JM; Kelleher J; Walters MP; Johnson AW
J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S22-9. PubMed ID: 2457072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
